Media stories about ReWalk Robotics (NASDAQ:RWLK) have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research firm rates the sentiment of media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. ReWalk Robotics earned a news sentiment score of 0.15 on Accern’s scale. Accern also assigned media headlines about the medical device company an impact score of 47.4210312773093 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Here are some of the media headlines that may have effected Accern Sentiment’s rankings:

A number of equities research analysts have commented on RWLK shares. Canaccord Genuity restated a “buy” rating on shares of ReWalk Robotics in a report on Monday, June 12th. Zacks Investment Research upgraded shares of ReWalk Robotics from a “hold” rating to a “buy” rating and set a $1.50 price target for the company in a report on Thursday, May 11th. Finally, Oppenheimer Holdings, Inc. restated an “outperform” rating and issued a $4.00 price target (down from $7.00) on shares of ReWalk Robotics in a report on Wednesday, May 10th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company’s stock. ReWalk Robotics has an average rating of “Hold” and a consensus price target of $4.00.

ReWalk Robotics (NASDAQ RWLK) traded down 1.82% on Friday, hitting $1.35. 135,074 shares of the company’s stock were exchanged. The firm has a 50 day moving average price of $1.44 and a 200-day moving average price of $1.68. The stock’s market cap is $29.36 million. ReWalk Robotics has a 52-week low of $1.10 and a 52-week high of $6.50.

ReWalk Robotics (NASDAQ:RWLK) last released its earnings results on Thursday, August 3rd. The medical device company reported ($0.29) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.35) by $0.06. The firm had revenue of $2.01 million for the quarter, compared to the consensus estimate of $1.71 million. ReWalk Robotics had a negative net margin of 389.13% and a negative return on equity of 528.26%. The company’s revenue was up 145.7% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.64) EPS. Analysts predict that ReWalk Robotics will post ($1.30) earnings per share for the current fiscal year.

In related news, major shareholder Scp Vitalife Partners (Israel) sold 9,271 shares of the stock in a transaction dated Monday, June 26th. The shares were sold at an average price of $3.00, for a total transaction of $27,813.00. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Wayne Weisman sold 87,000 shares of the stock in a transaction dated Tuesday, June 27th. The shares were sold at an average price of $3.05, for a total transaction of $265,350.00. The disclosure for this sale can be found here. Insiders sold a total of 199,883 shares of company stock worth $604,772 over the last ninety days. Insiders own 13.70% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Somewhat Positive News Coverage Somewhat Unlikely to Affect ReWalk Robotics (RWLK) Share Price” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The correct version of this report can be viewed at https://www.thecerbatgem.com/2017/08/19/rewalk-robotics-rwlk-given-news-impact-rating-of-0-15-updated.html.

About ReWalk Robotics

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.

Insider Buying and Selling by Quarter for ReWalk Robotics (NASDAQ:RWLK)

Receive News & Stock Ratings for ReWalk Robotics Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics Ltd and related stocks with our FREE daily email newsletter.